|
| | Issue Date | Title | Author(s) |
| 1 | 30-Jul-2020 | A Novel SERPINB1 Single-Nucleotide Polymorphism Associated With Glycemic Control and β-Cell Function in Egyptian Type 2 Diabetic Patients | Kassem, Dina ; Adel, Aya ; Sayed, Ghada H.; Kamal, Mohamed |
| 2 | 2023 | Abstract 1596: The promising recipe sorafenib rosiglitazone and adipogenesis inducers cocktail for in vitro hepatocellular carcinoma differentiation induction besiege carcinogenesis | Anis, Aya; Mostafa, Ahmed M. ; Prof. Hamdy, Nadia M. ; Sultan, Ahmed S. |
| 3 | 2021 | Abstract 428: Long-term survival outcomes in Egyptian female breast cancer patients with and without BRCA mutations | AbdelHamid, Sherihan ; El-Mesallamy, Hala Osman; AbdelAziz, Hany; zekri, Abdel-Rahman N. |
| 4 | 19-Dec-2023 | Acetaminophen-traces bioremediation with novel phenotypically and genotypically characterized 2 Streptomyces strains using chemo-informatics, in vivo, and in vitro experiments for cytotoxicity and biological activity | Embarez, Donia H; Razek, Ahmed S Abdel; Basalious, Emad B; Prof. Hamdy, Nadia M. |
| 5 | Feb-2012 | Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease | El-Mesallamy, Hala O; Prof. Hamdy, Nadia M. ; Salman, Tarek M; Ibrahim, Sherine M |
| 6 | 2023 | Adipose tissue‐derived mesenchymal stem cells ameliorate cognitive impairment in Alzheimer's disease rat model: Emerging role of SIRT1 | Nabil, Mohamed; Kassem, Dina ; Ali, Azza A.; El‐Mesallamy, Hala O. |
| 7 | 21-Oct-2024 | Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine | Basalious, Emad B; Kabel, Ahmed M; Nossier, Eman S; Abadi, Ashraf H; Nasr, Maha; Prof. Hamdy, Nadia M. ; El-Sisi, Mona G |
| 8 | 2018 | Alteration of metabolic genes in peripheral blood isolated from patients with acute myocardial infarction | Wasfey, Eman; Abd El-Razik, Rania; Prof. Hamdy, Nadia M. ; El-Kilany, Wael; El-Mesallamy, Hala |
| 9 | 1-Mar-2022 | Anticancer Effects with Molecular Docking Confirmation of Newly Synthesized Isatin Sulfonamide Molecular Hybrid Derivatives against Hepatic Cancer Cell Lines | Eldeeb, Mahmoud; Sanad, Eman F. ; Ragab, Ahmed; Ammar, Yousry A. ; Mahmoud, Khaled; Ali, Mamdouh M.; Prof. Hamdy, Nadia M. |
| 10 | 2011 | Apelin serum level in Egyptian patients with chronic hepatitis C | El-Mesallamy, Hala O; Prof. Hamdy, Nadia M. ; Rizk, Hanan H; El-Zayadi, Abdel-Rahman |
| 11 | 1-Aug-2016 | Association of expression levels of pluripotency/stem cell markers with the differentiation outcome of Wharton's jelly mesenchymal stem cells into insulin producing cells | Kassem, Dina ; El-Kholy, Abd El Latif G.; El-Mesallamy, Hala O.; Kamal, Mohamed |
| 12 | Feb-2012 | Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor | Swellam, Menha; Prof. Hamdy, Nadia M. |
| 13 | 18-Mar-2016 | Beclin-1 and hypoxia-inducible factor-1α genes expression: Potential biomarkers in acute leukemia patients | Prof. Hamdy, Nadia M. ; Hegab, Hany M; El-Mesallamy, Hala O; Radwan, Sara |
| 14 | May-2023 | Beyond mechanical loading: The metabolic contribution of obesity in osteoarthritis unveils novel therapeutic targets | Sobieh, Basma H; El-Mesallamy, Hala O; Kassem, Dina |
| 15 | 2021 | Biochemical Oncology for Personalized and Precision Medicine | Prof. Hamdy, Nadia M. |
| 16 | 2018 | Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach | El-Mesallamy, Hala O; El Magdoub, Hekmat M; Chapman, James M; Prof. Hamdy, Nadia M. ; Schaalan, Mona F; Hammad, Lamiaa N; Berger, Sondra H |
| 17 | 3-Dec-2020 | BRCA1 and BRCA2 truncating mutations and variants of unknown significance in Egyptian female breast cancer patients | AbdelHamid, Sherihan ; Abdel-Rahman N. Zekri; Hany M. AbdelAziz; Hala O. El-Mesallamy |
| 18 | 5-Feb-2024 | Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma | Khodair, Ahmed I; Cagle-White, Brittnee; Abdel Aziz, May H; Hanafy, Mahmoud Kh; Mowafy, Samar; Prof. Hamdy, Nadia M. ; Kassab, Shaymaa E; El-Hallouty, Salwa M. |
| 19 | 31-Dec-2023 | CCDC144NL-AS1/hsa-miR-143-3p/HMGA2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision | Abd El Fattah, Yasmine K; Abulsoud, Ahmed I; AbdelHamid, Sherihan G; AbdelHalim, Sherif; Prof. Hamdy, Nadia M. |
| 20 | 31-Dec-2023 | CCDC144NL-AS1/hsa-miR-143-3p/HMGA2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision | Abd El Fattah, Yasmine K; Abulsoud, Ahmed I; AbdelHamid, Sherihan G; AbdelHalim, Sherif; Prof. Hamdy, Nadia M. |
